Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2009

Popp Julius, Lewczuk Piotr, Linnebank Michael, Cvetanovska Gabriela, Smulders Yvo, Kölsch Heike, Frommann Ingo, Kornhuber Johannes, Maier Wolfgang, Jessen Frank

Abstract excerpt

Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may contribute to the disease pathophysiology by increasing both amyloid-beta (Abeta) production and phosphorylated tau (P-tau) accumulation. Here, we evaluated the relationship between the cerebrospinal fluid (CS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to tau Proteins
Share to Tetrahydrofolates
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homocysteine

Share to Multivariate Analysis

Share to Neuropsychological Tests

Share to Peptide Fragments

Share to S-Adenosylmethionine

Source

Identifiers

PMID: 19661622
DOI: 10.3233/JAD-2009-1187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19661622-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.PMID 19661622Read ↗

Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype.Semantic proximity Read ↗

Homocysteine and cognitive function in elderly people.Semantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.Semantic proximity Read ↗

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.Semantic proximity Read ↗

Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.Semantic proximity Read ↗

Abnormal Homocysteine Metabolism: An Insight of Alzheimer’s Disease from DNA MethylationSemantic proximity Read ↗

Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia.Semantic proximity Read ↗

The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration.Semantic proximity Read ↗

The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Semantic proximity Read ↗

Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults.Semantic proximity Read ↗

Methionine synthase polymorphism is a risk factor for Alzheimer disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.